NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 107 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,171 | -82.7% | 452 | -72.8% | 0.00% | – |
| Q1 2023 | $6,777 | +13.5% | 1,661 | +39.7% | 0.00% | – |
| Q4 2022 | $5,969 | +198.4% | 1,189 | +761.6% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 138 | +112.3% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 65 | -86.6% | 0.00% | – |
| Q1 2022 | $7,000 | +40.0% | 486 | +57.3% | 0.00% | – |
| Q4 2021 | $5,000 | +150.0% | 309 | +191.5% | 0.00% | – |
| Q3 2021 | $2,000 | -75.0% | 106 | -60.7% | 0.00% | – |
| Q1 2021 | $8,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +700.0% | 270 | +500.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |